Skip to content
KYAN Therapeutics

KYAN Therapeutics

KYAN’s mission is to unlock the full potential of combination therapies.

  • About
  • Platform
  • News
  • Team
  • Partners
  • Contact

Category: Nucleic Acids

KYAN Therapeutics Announces Collaboration with Institute of Molecular and Cell Biology for Accelerated Drug Discovery and Development of Nucleic Acids

August 23, 2021August 24, 2021 kyanetics

We have entered into a collaboration with Institute of Molecular and Cell Biology to discover and develop next-generation nucleic acid […]

Nucleic Acids, Optim.AI Platform

Recent Posts

  • KYAN Therapeutics Announces Collaboration with Institute of Molecular and Cell Biology for Accelerated Drug Discovery and Development of Nucleic Acids
  • KYAN Therapeutics Exclusively Licenses Small Molecule
  • AI Platform Aids Treatment for Relapsed Lymphoma
  • Global Release of Powbab Liver Cleanse Detox

Categories

  • Consumer Health
  • Drug Development
  • Lymphoma
  • Nucleic Acids
  • Optim.AI Platform

About KYAN

KYAN’s mission is to unlock the full potential of combination therapies, addressing unmet needs where monotherapies and single target development efforts fail.

Contact Information

Address: 83 Science Park Drive, The Curie, #02-03/04, Singapore 118258

Phone: +65 9730 2672

Email: contact@kyantherapeutics.com
Copyright © 2021. KYAN Therapeutics, Inc. All Rights Reserved.